5-Amino-1MQ vs Semaglutide
| Attribute | 5-Amino-1MQ NNMT inhibitor | Semaglutide GLP-1 receptor agonist |
|---|---|---|
| Category | Mitochondrial Health & Energy | Weight Loss & Metabolism |
| Best known for | Metabolic and fat-cell research | Weight loss and blood sugar research |
| In plain English | By inhibiting NNMT, 5-amino-1MQ keeps more NAD+ around and pushes fat cells toward burning rather than storing energy. | Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down. |
| How it works | Inhibits NNMT in adipocytes, increasing intracellular NAD+ and SAM and shifting metabolism toward fat oxidation. | Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling. |
| Researchers study | Obesity, NAFLD, and muscle stem cell research. | Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation. |
| Internet discussion | Discussed as an oral metabolic compound without GLP-1 side effects. | The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions. |
5-Amino-1MQ
Metabolic and fat-cell research
By inhibiting NNMT, 5-amino-1MQ keeps more NAD+ around and pushes fat cells toward burning rather than storing energy.
Inhibits NNMT in adipocytes, increasing intracellular NAD+ and SAM and shifting metabolism toward fat oxidation.
Obesity, NAFLD, and muscle stem cell research.
Discussed as an oral metabolic compound without GLP-1 side effects.
5-Amino-1MQ is an NNMT inhibitor studied for adipocyte metabolism and weight research.
Semaglutide
Weight loss and blood sugar research
Semaglutide mimics the hormone your gut releases when you eat. The brain reads it as 'we're full,' appetite drops, and stomach emptying slows down.
Activates the GLP-1 receptor in the pancreas, brain, and gut — increasing insulin secretion, slowing gastric emptying, and reducing appetite through hypothalamic signaling.
Glycemic control, weight reduction, cardiovascular outcomes, and emerging research in addiction and neuroinflammation.
The internet talks about semaglutide constantly — 'Ozempic face,' food noise reduction, alcohol cravings dropping, and dose-titration questions.
Semaglutide is the reference GLP-1 agonist — well-studied for blood sugar control and significant weight reduction.